Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_4
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD

NCT02537899
unknown

NeuroAiD Safe Treatment Registry

NCT02536079
completedphase_3

CHInese Medicine NeuroAid Efficacy on Stroke Recovery

NCT00554723
completedphase_2

Study of NeuroAid In Enhancing Recovery After Stroke

NCT00721825

Clinical Trials (4)

Showing 4 of 4 trials
NCT02537899Phase 4

Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD

Completed
NCT02536079

NeuroAiD Safe Treatment Registry

Unknown
NCT00554723Phase 3

CHInese Medicine NeuroAid Efficacy on Stroke Recovery

Completed
NCT00721825Phase 2

Study of NeuroAid In Enhancing Recovery After Stroke

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4